Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
As of close of business last night, Insmed Inc’s stock clocked out at $71.57, down -0.35% from its previous closing price of $71.82. In other words, the price has decreased by -$0.35 from its previous closing price. On the day, 2.06 million shares were traded. INSM stock price reached its highest trading level at $72.1 during the session, while it also had its lowest trading level at $70.6325.
Ratios:
To gain a deeper understanding of INSM’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.53 and its Current Ratio is at 2.71. In the meantime, Its Debt-to-Equity ratio is 35.53 whereas as Long-Term Debt/Eq ratio is at 29.43.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Truist on April 23, 2024, initiated with a Buy rating and assigned the stock a target price of $48.
On February 15, 2024, Wolfe Research started tracking the stock assigning a Outperform rating and target price of $42.
On December 08, 2023, Wells Fargo started tracking the stock assigning a Overweight rating and target price of $55.Wells Fargo initiated its Overweight rating on December 08, 2023, with a $55 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Sep 10 ’24 when Schaeffer Orlov S Nicole sold 37,575 shares for $71.50 per share. The transaction valued at 2,686,615 led to the insider holds 100,100 shares of the business.
Schaeffer Orlov S Nicole bought 37,575 shares of INSM for $2,679,097 on Sep 10 ’24. On Sep 06 ’24, another insider, Flammer Martina M.D., who serves as the Chief Medical Officer of the company, sold 149,002 shares for $71.23 each. As a result, the insider received 10,613,387 and left with 106,134 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, INSM now has a Market Capitalization of 12342174720 and an Enterprise Value of 12428204032. For the stock, the TTM Price-to-Sale (P/S) ratio is 37.43 while its Price-to-Book (P/B) ratio in mrq is 307.29. Its current Enterprise Value per Revenue stands at 37.821 whereas that against EBITDA is -19.574.
Stock Price History:
Over the past 52 weeks, INSM has reached a high of $80.53, while it has fallen to a 52-week low of $21.92. The 50-Day Moving Average of the stock is -3.10%, while the 200-Day Moving Average is calculated to be 67.96%.
Shares Statistics:
It appears that INSM traded 2.53M shares on average per day over the past three months and 1661260 shares per day over the past ten days. A total of 171.85M shares are outstanding, with a floating share count of 167.48M. Insiders hold about 2.54% of the company’s shares, while institutions hold 105.37% stake in the company. Shares short for INSM as of 1723680000 were 13504646 with a Short Ratio of 5.35, compared to 1721001600 on 14868059. Therefore, it implies a Short% of Shares Outstanding of 13504646 and a Short% of Float of 7.969999999999999.
